Order Article Reprints

Rosier M, Krstulović A, Kim HR, Kaur N, Enakireru EM, Symmes D, Dobra K, Chen R, Evans CA, Gad AKB. The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells. Cancers. 2025; 17(1):81. https://doi.org/10.3390/cancers17010081

Rosier, Marieke, Anja Krstulović, Hyejeong Rosemary Kim, Nihardeep Kaur, Erhumuoghene Mary Enakireru, Deebie Symmes, Katalin Dobra, Ruihuan Chen, Caroline A. Evans, and Annica K. B. Gad. 2025. "The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells" Cancers 17, no. 1: 81. https://doi.org/10.3390/cancers17010081

Rosier, M., Krstulović, A., Kim, H. R., Kaur, N., Enakireru, E. M., Symmes, D., Dobra, K., Chen, R., Evans, C. A., & Gad, A. K. B. (2025). The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells. Cancers, 17(1), 81. https://doi.org/10.3390/cancers17010081